2025年1月7日 · Mopral is used to treat conditions in which the stomach produces too much acid such as Zollinger-Ellison syndrome in adults. Prescription Mopral is used to allow the esophagus to heal and prevent further damage to the esophagus in adults and children 1 year of age and older with GERD.

2024年5月13日 · Omeprazole is used to treat excess stomach acid in conditions such as non cancerous stomach ulcers, gastroesophageal reflux disease (GERD), active duodenal ulcer, Zollinger-Ellison syndrome and erosive esophagitis. Omeprazole works by blocking gastric acid production and is from the group of medicines called proton pump inhibitors.

奥美拉唑，主要用于 十二指肠溃疡 和 卓-艾综合征，也可用于胃溃疡和反流性食管炎；静脉注射可用于消化性溃疡急性出血的治疗。 与阿莫西林和克林霉素或与甲硝唑与克拉霉素合用，以杀灭 幽门螺杆菌。 1.用于胃溃疡、十二指肠溃疡。 奥美拉唑与抗生素联合使用的二联和三联用药方案，可用于治疗幽门螺旋杆菌（HP）相关的消化性溃疡。 2.用于反流性食管炎、胃泌素瘤（卓-艾综合征）。 3.奥美拉唑静脉注射可用于消化性溃疡急性出血的治疗，如急性胃黏膜病变出血。 为白 …

2025年1月7日 · Mopralpro belongs to a class of antisecretory compounds, the substituted benzimidazoles, that suppress gastric acid secretion by specific inhibition of the H+/K+ …

A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H (+)-K (+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Omeprazole is a Proton Pump Inhibitor.

Gastro-resistant capsule, hard; Powder and solvent for solution for injection; Powder for solution for infusion. Mopral is indicated in adults and children over 1 year of age and > 10kg. Mopral …

It is a specific inhibitor of the acid pump in the parietal cell. It is rapidly acting and provides control through reversible inhibition of gastric acid secretion with once daily dosing. This drug has …

Mopral is indicated for short-term treatment (4-8 weeks) of active benign gastric ulcer in adults. Mopral is indicated for the treatment of heartburn and other symptoms associated with GERD in pediatric patients and adults for up to 4 weeks.

Mopral is an inhibitor of H+ K+ ATPase. This medication inhibits the activity of H+-K+-ATPase in gastric parietal cells and thus blocks the final stage of hydrochloric acid secretion. This leads to a reduction in basal and stimulated secretion, regardless of the nature of the stimulus.

2025年2月26日 · Ce médicament appartient à la famille des inhibiteurs de la pompe à protons (IPP). Il diminue la sécrétion des acides gastriques et permet ainsi de combattre les troubles …